ArticleFrontiers in bioengineering and biotechnology2020

Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer.

Ze Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.